Literature DB >> 7389759

Studies on familial amyloid polyneuropathy in Ogawa Village, Japan.

S Kito, E Itoga, K Kamiya, T Kishida, Y Yamamura.   

Abstract

A newly discovered large concentration of familial amyloid polyneuropathy (FAP) in Japan is clinically outlined. The importance of the urinary secretion of IgA in these cases is stressed. Dimethyl sulfoxide administration to these patients induced clinical improvements accompanied by increased excretion of low molecular weight proteins. Amino acid composition of amyloid protein of the Ogawa village-type FAP cases was similar to that of primary amyloidosis.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7389759     DOI： 10.1159/000115139

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


  11 in total

1.  "Sporadic" prealbumin-related amyloid polyneuropathy: report of two cases.

Authors:  M Yamada; H Tsukagoshi; J Satoh; S Ishiai; M Nakazato; H Furuya; H Sasaki; Y Sakaki; T Yokota
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

2.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.

Authors:  K Yamamoto; S Ikeda; N Hanyu; S Takeda; N Yanagisawa
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

3.  Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments.

Authors:  Takaki Taniguchi; Masahiro Ando; Yuji Okamoto; Akiko Yoshimura; Yujiro Higuchi; Akihiro Hashiguchi; Nozomu Matsuda; Mamoru Yamamoto; Eisuke Dohi; Makoto Takahashi; Masanao Yoshino; Taichi Nomura; Masaaki Matsushima; Ichiro Yabe; Yui Sanpei; Hiroyuki Ishiura; Jun Mitsui; Masanori Nakagawa; Shoji Tsuji; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-01-14       Impact factor: 3.172

4.  Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

Authors:  U Drugge; R Andersson; F Chizari; M Danielsson; G Holmgren; O Sandgren; A Sousa
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

5.  Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin.

Authors:  M Tanaka; S Hirai; E Matsubara; K Okamoto; M Morimatsu; M Nakazato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

6.  Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs.

Authors:  H Furuya; K Yoshioka; H Sasaki; Y Sakaki; M Nakazato; H Matsuo; A Nakadai; S Ikeda; N Yanagisawa
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 7.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Araki; S Yi; T Murakami; S Watanabe; S Ikegawa; K Takahashi; K Yamarnura
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

8.  Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77).

Authors:  M M Reilly; D Adams; M B Davis; G Said; A E Harding
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

9.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Yi; K Takahashi; M Naito; F Tashiro; S Wakasugi; S Maeda; K Shimada; K Yamamura; S Araki
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

Review 10.  Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.

Authors:  Shukuro Araki; Yukio Ando
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.